Item 9 Labs Corp (INLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 183 | 101 | 22 | 86 | 442 |
| Receivables | 968 | 596 | 602 | 586 | 592 |
| Inventories | 1,899 | 2,641 | 1,937 | 2,464 | 4,131 |
| TOTAL | $3,347 | $3,681 | $2,846 | $3,553 | $5,692 |
| Non-Current Assets | |||||
| PPE Net | 24,602 | 24,854 | 23,009 | 21,020 | 26,307 |
| Intangibles | 68,918 | 69,384 | 69,678 | 69,975 | 77,456 |
| Other Non-Current Assets | 15,148 | 16,207 | 19,137 | 16,214 | 11,073 |
| TOTAL | $108,668 | $110,445 | $111,824 | $107,208 | $114,836 |
| Total Assets | $112,016 | $114,127 | $114,670 | $110,762 | $120,528 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,852 | 6,920 | 6,379 | 6,422 | 5,820 |
| Accrued Expenses | 12,116 | 9,533 | 9,327 | 8,485 | 5,372 |
| Other current liabilities | 5,500 | 5,500 | 5,500 | 5,500 | N/A |
| TOTAL | $58,813 | $47,136 | $46,575 | $40,586 | $39,470 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 8,287 | 6,936 | 7,217 | 1,449 |
| Deferred Revenues | 175 | 175 | 170 | 220 | 215 |
| Other Non-Current Liabilities | 141 | 591 | 461 | 732 | 749 |
| TOTAL | $558 | $9,307 | $7,738 | $8,235 | $2,551 |
| Total Liabilities | $59,371 | $56,444 | $54,313 | $48,821 | $42,021 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 102,362 | 101,756 | 100,788 | 100,002 | 96,264 |
| Common Shares | 11 | 11 | 11 | 11 | 11 |
| Retained earnings | -77,602 | -71,691 | -68,274 | -65,017 | -46,568 |
| Other shareholders' equity | -455 | -451 | -461 | -471 | -436 |
| TOTAL | $52,644 | $57,683 | $60,358 | $61,941 | $78,507 |
| Total Liabilities And Equity | $112,016 | $114,127 | $114,670 | $110,762 | $120,528 |